Dan Du
Impact in
- Molecular Biology top 10%
- Natural product bioactivities and synthesis
- RNA modifications and cancer
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Natural product bioactivities and synthesis 9
- Circular RNAs in diseases 7
- RNA modifications and cancer 5
- Surgery 28
- Pancreatitis Pathology and Treatment 23
- Co-authors
- Meng Gong (7 shared papers)Yu Hao (1 shared paper)Junbing Huang (1 shared paper)Jing Qu (11 shared papers)Qing Xia (25 shared papers)Shuang‐Gang Ma (8 shared papers)Shisheng Wang (5 shared papers)Shi‐Shan Yu (8 shared papers)
- Journals
- Phytomedicine (5 papers)Analytical Chemistry (4 papers)Journal of Chromatography B (3 papers)Acta Pharmaceutica Sinica B (3 papers)Molecular & Cellular Proteomics (3 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Dan Du
98 papers receiving 2.3k citations
Dan Du's Hit Papers
Peers
Comparison fields: 5 of 157
- Molecular Biology 900
- Cancer Research 171
- Pharmacology 167
- Rehabilitation 64
- Complementary and alternative medicine 74
Countries citing papers authored by Dan Du
This map shows the geographic impact of Dan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Du more than expected).
Fields of papers citing papers by Dan Du
This network shows the impact of papers produced by Dan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Du. The network helps show where Dan Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF Hit paper breakdown → | 2020 | 321 |
| 2 | 2020 | 113 | |
| 3 | 2017 | 108 | |
| 4 | Effects of camera viewing angles on tracking kinematic gait patterns using Azure Kinect, Kinect v2 and Orbbec Astra Pro v2 Hit paper breakdown → | 2021 | 96 |
| 5 | 2010 | 95 | |
| 6 | 2020 | 78 | |
| 7 | 2020 | 59 | |
| 8 | 2010 | 50 | |
| 9 | 2009 | 45 | |
| 10 | 2018 | 43 | |
| 11 | 2013 | 42 | |
| 12 | 2017 | 41 | |
| 13 | 2022 | 40 | |
| 14 | 2022 | 37 | |
| 15 | 2005 | 35 | |
| 16 | 2022 | 34 | |
| 17 | 2012 | 34 | |
| 18 | 2012 | 32 | |
| 19 | 2021 | 29 | |
| 20 | 2010 | 29 |
About Dan Du
Dan Du is a scholar working on Molecular Biology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Epidemiology, having authored 105 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (23 papers), Natural product bioactivities and synthesis (9 papers), Circular RNAs in diseases (7 papers), Phytochemistry and Biological Activities (6 papers), Cancer-related molecular mechanisms research (5 papers), Liver Disease Diagnosis and Treatment (5 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Molecular Biology (900 citations), Cancer Research (171 citations), Pharmacology (167 citations), Rehabilitation (64 citations) and Complementary and alternative medicine (74 citations). Dan Du has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Meng Gong, Yu Hao, Junbing Huang, Jing Qu, Qing Xia, Shuang‐Gang Ma, Shisheng Wang, Shi‐Shan Yu, Wen Zheng and Yaohui Chen. Their work appears in journals such as Phytomedicine, Analytical Chemistry, Journal of Chromatography B, Acta Pharmaceutica Sinica B and Molecular & Cellular Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.